James E. Finch's Articles in Ovarian Cancer

  • Stimulating the Body’s Defenses to Fight Ovarian Cancer
    OvaRex® MAb is a monoclonal antibody – a biotech drug – designed to help the patient’s immune system recognize and more effectively fight ovarian cancer. OvaRex® MAb is given during the ‘watchful waiting’ period, following successful front-line therapy. It may become recognized as the most significant advance in ovarian cancer treatment since the use of chemotherapy to treat this illness.

© 2007 Article Dashboard. All Rights Reserved.
Use of our service is protected by our Privacy Policy and Terms of Service

Powered by Article Dashboard